Résultats de recherche
Accédez à votre compte en ligne Banque Populaire et à votre espace personnel sécurisé grâce à Cyberplus via l’application mobile ou votre ordinateur.
Découvrez l'offre Banque Populaire pour les particuliers : comptes, cartes, assurances, souscription et simulateurs en ligne.
Découvrez l'offre Banque Populaire Auvergne Rhône Alpes (BPAURA) pour les particuliers : comptes, cartes, assurances, souscription en ligne.
20 mai 2021 · B-cell prolymphocytic leukemia (B-PLL) is a very rare blood cancer. Experts used to classify B-PLL as a form of chronic lymphocytic leukemia (CLL).
B-cell prolymphocytic leukemia (B-PLL) is a very rare and typically aggressive malignancy (cancer) characterized by the out of control growth of B-cells (B-lymphocytes). B-cells are a type of white blood cell that is part of the immune system.
B-cell prolymphocytic leukemia, referred to as B-PLL, is a rare blood cancer. It is a more aggressive, but still treatable, form of leukemia . Specifically, B-PLL is a prolymphocytic leukemia (PLL) that affects prolymphocytes – immature forms of B-lymphocytes and T-lymphocytes – in the peripheral blood, bone marrow, and spleen.
B-cell prolymphocytic leukemia, also referred to as B-PLL, is a rare type of chronic lymphocytic leukemia that affects the prolymphocytes (B-cells) of the adaptive immune system. The disease represents less than 1% of all leukemia cases worldwide.
11 sept. 2019 · B-cell prolymphocytic leukemia (B-PLL) is a rare malignancy of mature B-cells with characteristic morphologic, immunophenotypic, cytogenetic, and molecular features characterized by late onset (median age 69 years), an aggressive clinical course, refractoriness to chemotherapy, and median survival of around three years.
1 févr. 2021 · Variable clinical course. A median OS of 3 years was reported; however this was prior to the advent of immunotherapy and targeted therapies. A more recent study of 34 B-PLL reported a median overall survival of 125 months.
25 avr. 2022 · B cell prolymphocytic leukemia (B-PLL) is a very rare B cell neoplasm comprised of so-called prolymphocytes, typically with involvement of the peripheral blood, bone marrow, and spleen. The name "prolymphocyte" is actually a misnomer, as the tumor cells in this disease are mature activated B cells. By definition, these prolymphocytes ...
